US equities |
NVDA $168.89 ▼-5.47% AMD $515.21 ▲+1.30% MU $725.11 ▼-1.10% MSFT $533.16 ▼-2.20% SNDK $859.99 ▼-2.99% SPCX $143.09 ▲+0.72% AMZN $270.87 ▲+1.48% AAPL $348.51 ▼-0.62%
FinancialContent

Novartis AG Common Stock (NY:NVS)

163.26 -0.43 (-0.26%)
Official Closing Price Updated: 7:00 PM EST, Nov 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Novartis AG Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
From Pomerantz LLP
Via GlobeNewswire
News headline image
At the Longevity Investors Conference in Gstaad, Investors Test Which Longevity Claims Hold Up
DATELINE]As longevity research moves from animal models into human trials, investors are asking a sharper question: what is science, and... 
Via Newsfile
News headline image
Leaders Face Stark Warning from Silicon Valley Veteran – The Old Way of Working is Dead
Via Get News
Topics Artificial Intelligence
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
Via Investor Brand Network
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
Via Investor Brand Network
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
Via Investor Brand Network
News headline image
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
From BioMedWire
Via GlobeNewswire
News headline image
2025 R&D Spending And Intensity Benchmarks
Via PRLog
Topics Supply Chain
News headline image
Hear from a prostate cancer patient about the one test more men should ask for
(Novartis) - Dr. Koo, EVP and CMO at Prostate Cancer Foundation, and Bill, who is living with prostate cancer, answer some frequently asked questions about PSMA testing. Talk to your doctor and visit... 
Via NewsUSA
News headline image
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
New report covers Nuvectis Pharma (NASDAQ: NVCT) as the company transitions from a single-drug oncology story into a late-stage rare-disease... 
Via Newsfile
MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5 Billion ADC Acquisition
Via Investor Brand Network
News headline image
Core Restore Founder Ann Peets Announces Bladder Leak Treatments In Charleston
Via Press Release Distribution Service
The Quest to Repair What Multiple Sclerosis Takes Away
Via Investor Brand Network
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
Via Investor Brand Network
Veteran Biopharma Engineer Ge Yang Attracts Investor Interest with Vision to Redefine Global Pharma Manufacturing
Via AB Newswire
News headline image
The Quest to Repair What Multiple Sclerosis Takes Away
From BioMedWire
Via GlobeNewswire
News headline image
Bionique Wins Dual Golds for “Exosome + Probiotic” Breakthrough in Women’s Microbiome Health
Via Get News
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
Via Investor Brand Network
News headline image
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
From BioMedWire
Via GlobeNewswire
News headline image
BIOCHINA2026 – Fusion Forward: Uniting the Global Biopharma Community in Suzhou
Via Press Release Distribution Service
News headline image
BIOCHINA2026 – Fusion Forward: Uniting the Global Biopharma Community in Suzhou
Via Get News
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
Via Investor Brand Network
News headline image
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NYSE:NVS),(NASDAQ:BCAX),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Digital Pharma Advances 2026: AI and Patient-Centric Strategies Transform Pharma Marketing
Via PRLog
Topics Artificial Intelligence
News headline image
2024 R&D Spending and Intensity Benchmarks
Via PRLog
Topics Supply Chain
News headline image
Gateway to Growth: Innovation and Opportunity at the 8th CIIE
Via Press Release Distribution Service
Topics Economy
News headline image
Gateway to Growth: Innovation and Opportunity at the 8th CIIE
Via Get News
Topics Economy
News headline image
Hazelden Betty Ford Foundation Appoints Four New Members to Its Board of Trustees
Center City, Minnesota--(Newsfile Corp. - July 31, 2025) - Hazelden Betty Ford Foundation, the nation's leading nonprofit system of addiction... 
Via Newsfile
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >